BOC Sciences

BOC Sciences supplies bulk compounds and custom chemical services to the pharmaceutical, agrochemical, and biotechnology industries. Core offerings include custom synthesis (chiral synthesis, nucleoside/nucleotide synthesis, glycan synthesis), cGMP manufacturing of nanoemulsions, analytical services (XDC analysis, crystallization, impurity identification), and contract purification. The company provides specialized platforms in drug delivery (liposome, nanoparticle, exosome, hydrogel, polymer-based), bioconjugation (Lys, Cys, site-specific, enzymatic conjugation), and ADC development (linker design, antibody modification, peptide-drug and small-molecule conjugates). Additional capabilities span microbial fermentation, ADMET & developability assessment, RNA therapeutics development, and isotope labeling services. Product portfolio includes APIs, GMP intermediates, pharmaceutical excipients, drug discovery compounds (inhibitors, PROTACs, vaccine adjuvants, impurities, metabolites), and life science reagents (oligonucleotides, enzymes, fluorescent probes, carbohydrates, phospholipids).